|
|
|
|
-
Sagent Pharmaceuticals To Acquire Remaining 50% Interest In Chinese Manufacturing JV
5/6/2013
|
-
Sagent Pharmaceuticals Q1 EPS $0.34 Vs. Loss $0.30 Year Ago
5/6/2013
|
|
|
-
Sagent Pharmaceuticals Appoints James Hussey As Its President, Effective March 25
3/19/2013
|
|
|
-
Sagent Pharma Announces Amendment To Supply Agreement With Actavis
3/5/2013
|
|
|
-
Sagent Pharma Announces Approval And Launch Of Zoledronic Acid Injection 4 Mg In Plastic Vial
3/5/2013
|